Targeted Lung Denervation (TLD)
Showing 1 - 25 of >10,000
COPD Trial (Targeted Lung Denervation)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Targeted Lung Denervation
- (no location specified)
Jul 21, 2023
COPD Trial in Chengdu (TLD, Sham TLD procedure, Standard of care)
Not yet recruiting
- COPD
- TLD
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Apr 3, 2023
COPD Trial in Worldwide (Targeted Lung Denervation (TLD), Optimal Medical Care)
Recruiting
- COPD
- Targeted Lung Denervation (TLD)
- Optimal Medical Care
-
Birmingham, Alabama
- +32 more
May 9, 2022
Hyperpolarized Xenon Functional Lung Imaging in COPD Patients
Not yet recruiting
- COPD
- Functional imaging of the lungs using MagniXene (hyperpolarized xenon-129) MRI
- (no location specified)
Apr 3, 2023
Targeted Lung Denervation on Severe and Very Severe COPD
Withdrawn
- COPD
- Targeted Lung Denervation (TLD)
- (no location specified)
Feb 14, 2019
Emergence of HIV Drug Resistance Following Initiation of TLD
Recruiting
- HIV-1-infection
-
Port-au-Prince, Bicentaire, Haiti
- +13 more
Feb 22, 2022
Airway Microenvironment in Patients Undergoing Surgical and
Recruiting
- Chronic Obstructive Pulmonary Disease
- +2 more
-
London, Chelsea, United Kingdom
- +1 more
Sep 14, 2021
Hypertension Trial in China (SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator)
Active, not recruiting
- Hypertension
- SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator
-
Beijing, Beijing, China
- +19 more
Oct 24, 2022
Dolutegravir Implementation in Sub-Saharan Africa
Recruiting
- HIV-1-infection
- This is an observational study only.
-
Somkele, KwaZulu-Natal, South Africa
- +1 more
Feb 15, 2022
The Long-term Safety and Effect of Renal Denervation
Recruiting
- Hypertension
- Renal denervation
-
London, Middlesex, United KingdomHammersmith Hospital
Apr 5, 2023
Chronic Kidney Diseases, Heart Failure, End Stage Renal Disease Trial in Perth (Renal Denervation)
Recruiting
- Chronic Kidney Diseases
- +2 more
- Renal Denervation
-
Perth, Western Australia, AustraliaRoyal Perth Hospital
Jan 19, 2023
NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)
Not yet recruiting
- NSCLC Stage IV
- ALK Fusion Protein Expression
- Peptide vaccine
- (no location specified)
Jul 21, 2023
Type 2 Diabetes (T2DM) Trial in Nanjing (Endovascular denervation System (Generator and Catheter ))
Recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Endovascular denervation System (Generator and Catheter )
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Southeast University
Jan 2, 2023
Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- Large Cell Neuroendocrine Carcinoma of the Lung
- LB2102
- (no location specified)
Jan 10, 2023
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation Trial in New York (Renal Denervation, Catheter Ablation)
Not yet recruiting
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation
- Renal Denervation
- Catheter Ablation
-
New York, New YorkMount Sinai Hospital
Aug 4, 2023
Osteoarthritis Wrist Trial (Self-managed exercise therapy program, Partial wrist denervation)
Not yet recruiting
- Osteoarthritis Wrist
- Self-managed exercise therapy program
- Partial wrist denervation
- (no location specified)
Oct 24, 2023
Atrial Fibrillation Trial in United States (renal denervation, Catheter ablation)
Recruiting
- Atrial Fibrillation
- renal denervation
- Catheter ablation
-
Phoenix, Arizona
- +12 more
Dec 23, 2022
Peripheral Lung Tumor Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)
Not yet recruiting
- Peripheral Lung Tumor
- Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
- (no location specified)
Jun 15, 2023
Lung Cancer Trial (LungTalk, Non-tailored intervention - Standard of practice)
Not yet recruiting
- Lung Cancer
- LungTalk
- Non-tailored intervention - Standard of practice
- (no location specified)
Apr 10, 2023
Efficacy of Targeted Therapy for NSCLC
Recruiting
- Evaluation
- +2 more
- RecistTM criteria
-
Chongqing, Chongqing, ChinaCancer Center, Dapping Hospital, Army Medical Center of PLA
Nov 15, 2023
Group 2 Pulmonary Hypertension, Heart Failure Trial (Gradient Denervation System)
Not yet recruiting
- Group 2 Pulmonary Hypertension
- Heart Failure
- Gradient Denervation System
- (no location specified)
Sep 18, 2023
Coronary Microvascular Dysfunction, Resistant Hypertension, Hypertensive Heart Disease Trial (Invasive Physiological Assessment
Not yet recruiting
- Coronary Microvascular Dysfunction
- +2 more
- Invasive Physiological Assessment of Coronary Circulation
- (no location specified)
Aug 9, 2023
Participants Undergoing Targeted Lung Health Checks
Not yet recruiting
- Lung Cancer
-
London, United KingdomUniversity College London Hospitals NHS Foundation Trust
Jun 5, 2023
Heart Failure Patients With Pulmonary Hypertension Trial in Tbilisi (Gradient Denervation System)
Recruiting
- Heart Failure Patients With Pulmonary Hypertension
- Gradient Denervation System
-
Tbilisi, Georgia
- +1 more
Jul 10, 2023